These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 441482)

  • 41. [Therapeutic comparison between digoxin, beta-methyl-digoxin and beta-acetyl-digoxin].
    Gruppillo P; Padovan GC; Tomaini MD; Masoni C
    Clin Ter; 1981 Nov; 99(3):281-93. PubMed ID: 7307456
    [No Abstract]   [Full Text] [Related]  

  • 42. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin].
    Belz GG; Wintrich R
    Z Kardiol; 1984 Jan; 73(1):29-33. PubMed ID: 6367246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.
    Yahalom J; Klein HO; Kaplinsky E
    Chest; 1977 May; 71(5):592-6. PubMed ID: 856557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of medigoxin in outpatients.
    Smith WR; Rodgers EM; Nicholson PW; Humm RP; Gettins DA; Dobbs SM; Deshmukh AA
    Eur J Clin Pharmacol; 1981 Mar; 19(4):251-8. PubMed ID: 7286028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.
    Bøtker HE; Toft P; Klitgaard NA; Simonsen EE
    Br Heart J; 1991 Jun; 65(6):337-41. PubMed ID: 2054244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of action of beta-methyldigoxin and digoxin utilizing systolic time intervals.
    Katdare AD; Namjoshi SA; Nair KG
    J Int Med Res; 1980; 8(1):50-5. PubMed ID: 7358204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics of beta-methyl-digoxin in patients on dialysis].
    Modrić B; Kovarbasić B
    Vojnosanit Pregl; 1981; 38(2):88-92. PubMed ID: 7257229
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparative pharmacokinetics and pharmacodynamics of cardiac glycosides.
    Kelman AW; Sumner DJ; Lonsdale M; Lawrence JR; Whiting B
    Br J Clin Pharmacol; 1980 Aug; 10(2):135-43. PubMed ID: 7426275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.
    Schwartz JB; Keefe D; Kates RE; Kirsten E; Harrison DC
    Circulation; 1982 Jun; 65(6):1163-70. PubMed ID: 7074776
    [No Abstract]   [Full Text] [Related]  

  • 52. Medigoxin.
    Lancet; 1978 Nov; 2(8100):1135. PubMed ID: 82691
    [No Abstract]   [Full Text] [Related]  

  • 53. [No advantages of acetyldigoxin and methyldigoxin compared to digoxin].
    Kuhlmann J
    Dtsch Med Wochenschr; 1982 May; 107(21):831-3. PubMed ID: 7042270
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of patients with chronic atrial fibrillation.
    Salhadin P; Bran M; De Marneffe M; Denolin H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):295S-296S. PubMed ID: 7104150
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin.
    Di Fronzo G; Bertuzzi A; Ronchi E; Villani FP; Ronchetti L
    Cancer Chemother Pharmacol; 1979; 2(3):169-73. PubMed ID: 455570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing?
    Zarowitz BJ; Gheorghiade M
    Am Heart J; 1992 May; 123(5):1401-3. PubMed ID: 1349453
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of digoxin and medigoxin in normal subjects.
    Hayward RP; Greenwood H; Hamer J
    Br J Clin Pharmacol; 1978 Jul; 6(1):81-6. PubMed ID: 666950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of metildigoxin and digoxin in geriatric patients with normal and elevated serum creatinine levels.
    Kaufmann B; Olcay A; Schaumann W; Teufel W; Weib W
    Clin Pharmacokinet; 1981; 6(6):463-8. PubMed ID: 7318305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic effectiveness of beta-methyldigoxin].
    Król W; Kokot F; Sniezek M; Siedlecka B
    Pol Tyg Lek; 1979 Feb; 34(6):221-3. PubMed ID: 441028
    [No Abstract]   [Full Text] [Related]  

  • 60. [Quadratic analysis of left ventricular ejection phase volume using a M-mode echocardiogram, and the effects of beta-methyldigoxin, nifedipine, physical exercise and propranolol on new parameters].
    Suzuki K
    Nihon Ika Daigaku Zasshi; 1988 Dec; 55(6):527-38. PubMed ID: 3209669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.